Exploring how hyperactivating cancer pathways can be a novel synthetic lethality approach in oncology
Explore the revolutionary protein degradation therapies entering clinical trials for cancer treatment, offering new hope against 'undruggable' targets.
Recent research reveals USPs as master regulators of tumor survival, metastasis, and drug resistance, making them prime targets for next-generation therapies.